The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial
暂无分享,去创建一个
S. Kudoh | Y. Sugiyama | Y. Kondoh | H. Taniguchi | M. Ebina | T. Nukiwa | M. Suga | Hiroki Takahashi | T. Ogura | A. Azuma | Y. Taguchi | K. Nakata | A. Sato